A5093226064- BRCA gene mutations in cancer
- Thyroid and Parathyroid Surgery
- Academic Research in Diverse Fields
- Thyroid Cancer Diagnosis and Treatment
- Public Health in Brazil
- Healthcare during COVID-19 Pandemic
Instituto do Câncer do Estado de São Paulo
2024
Universidade de São Paulo
2024
Beneficência Portuguesa de São Paulo
2024
United Therapeutics (United States)
2024
Differentiated thyroid carcinoma (DTC) accounts for most cases of cancer, and the heterogeneity DTC requires that management decisions be taken by a multidisciplinary team involving endocrinologists, head neck surgeons, nuclear medicine physicians, pathologists, radiologists, radiation oncologists, medical oncologists. It is important nonspecialists to recognize refer patients with who will benefit from specialized approach. Recent advances in knowledge changes call need raise awareness on [...]
Introdução: O CDT tem bom prognóstico, com sobrevida em longo prazo superior a 90%. Entretanto, quando o érefratário à radioiodoterapia (CDT RAIR) taxa de sobrevida, dez anos, é 10%. A despeito da constante evolução nasopções terapêuticas, na perspectiva Saúde Suplementar, tratamento disponível baseia-se quimioterapia citotóxica, que apresenta baixa eficácia e importante toxicidade aos pacientes RAIR. Objetivos: Avaliar eficácia, segurança, custo-utilidade impacto orçamentário do mesilato...